Company news

Tectonic Therapeutic, Inc. news in 2024

Tectonic Therapeutic, Inc.'s news releases, calls and decks from 2024, newest first.

View company

Tectonic Therapeutic to Host KOL Event on the Unmet Need in Group 2 PH-HFpEF and TX45 as a Potential Treatment on Thursday, December 12, 2024

December 2, 2024

Tectonic Therapeutic To Present on December 3rd, 2024 at the Piper Sandler Healthcare Conference

November 25, 2024

Tectonic Therapeutic Announces Positive Phase 1a Results in AHA 2024 Presentation for TX45, a Long-acting, Fc-Relaxin Fusion Protein

November 10, 2024

Tectonic Therapeutic Announces Third Quarter 2024 Financial Results and Recent Business Highlights

November 6, 2024

Tectonic Therapeutic to Present Phase 1a Data at AHA 2024

October 21, 2024

Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45

September 18, 2024

Tectonic Therapeutic Announces Second Quarter 2024 Financial Results and Recent Business Highlights

August 13, 2024

Tectonic Therapeutic Announces US IND Clearance for Lead Program, TX45

July 29, 2024

Tectonic Therapeutic Appoints Daniel Lochner as Chief Financial Officer

June 2, 2024

AVROBIO and Tectonic Therapeutic Announce Merger

January 29, 2024

Decks in 2024